Clinical Trials

70 enrolled

Malignant Female Reproductive System Neoplasm

NCT03736889 2026-04-15

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

200 enrolled

MSI-H/dMMR Solid Tumors

NCT04886271 2026-04-15

Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid Tumors

Advanced Solid Tumor

NCT06638931 2026-04-15

ANTARES

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther solid neoplasmSarcomaThoracic

28 enrolled

Urachal adenocarcinoma, Urachal cancer, Fibrolamellar hepatocellular carcinoma, Secretory breast carcinoma, Carcinoma, Ovarian Epithelial, Adrenal Gland Neoplasms, Anus Neoplasms, Biliary Tract Neoplasms, Carcinosarcoma, Carcinoma, Adenoid Cystic, Fallopian Tube Neoplasms, Fibrosarcoma, Gallbladder Neoplasms, Granulosa Cell Tumor, Hemangiosarcoma, Leiomyosarcoma, Mesothelioma, Neuroblastoma, Parathyroid Neoplasms, Penile Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Thyroid Neoplasms, Trophoblastic Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Hepatoblastoma, Endodermal Sinus Tumor, Neuroectodermal Tumors, Primitive, Cholangiocarcinoma, Sertoli-Leydig Cell Tumor, Neurofibrosarcoma, Hemangioblastoma, Neuroendocrine Tumors

NCT06351371 2026-04-14

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

35 enrolled 10 charts

Malignant Solid Neoplasm

NCT06581432 2026-04-14

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

430 enrolled

Solid Tumours

NCT06619509 2026-04-14

A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

90 enrolled

Solid Tumours

NCT06679634 2026-04-14

Retinoblastoma Phase II Expanded Access Clinical Trial

30 enrolled

Retinoblastoma

NCT06009926 2026-04-13

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

Other neoplasmOther solid neoplasm

72 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT06136897 2026-04-13

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

35 enrolled 10 charts

Malignant Solid Neoplasm

NCT06360588 2026-04-13

Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

22 enrolled 9 charts

Malignant Solid Neoplasm

NCT07172919 2026-04-09

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

14 enrolled

Advanced Solid Tumors

NCT07415031 2026-04-08

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

170 enrolled

Solid Tumors

NCT07359820 2026-04-07

ReFocus202

30 enrolled

FGFR2 Gene Fusion/Rearrangement

NCT07514793 2026-04-07

Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma

37 enrolled

Mesothelioma

NCT04911907 2026-04-03

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

126 enrolled

Solid Tumor

NCT04589845 2026-04-02

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

920 enrolled 2 FDA

Solid Tumors

NCT07390383 2026-04-01

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

110 enrolled

Advanced Solid Tumour

NCT05960773 2026-03-27

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Phase 2 Suspended

9 enrolled

Mesothelioma, Malignant, Mesothelioma

NCT06503146 2026-03-27

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

CNSEndocrineGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcomaThoracic

320 enrolled

Urinary Bladder Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Ovarian Neoplasms, Paraganglioma, Pheochromocytoma, Sarcoma, Stomach Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT04891198 2026-03-25

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

126 enrolled

Solid Tumor

NCT07480733 2026-03-25

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

480 enrolled

Advanced Malignant Solid Tumors

NCT06651593 2026-03-24

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

40 enrolled

Solid Tumors

NCT06827054 2026-03-24

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Hematopoietic and Lymphatic System Neoplasm

NCT07032077 2026-03-20

A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors

100 enrolled

Solid Tumors

NCT04083976 2026-03-19

RAGNAR

316 enrolled 15 charts

Advanced Solid Tumor

NCT05023655 2026-03-17

Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation

Phase 2 Terminated

Solid Tumor

NCT06654050 2026-03-17

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Phase 2 Withdrawn

Mesothelioma, Malignant, Mesothelioma

NCT06840834 2026-03-16

Bi-MAPS

38 enrolled

Mesothelioma, Malignant

NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

133 enrolled

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

NCT07018622 2026-03-11

DAPA-ARMOR

46 enrolled

Solid Tumors

NCT07111546 2026-03-11

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

140 enrolled

Advanced Solid Tumour

NCT07196644 2026-03-11

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

125 enrolled

Solid Tumors Harboring MET Amplification

NCT07459920 2026-03-10

CAPTURE

156 enrolled

Advanced Malignant Solid Tumor

NCT07331155 2026-03-09

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

110 enrolled

Advanced Solid Tumour

NCT01761929 2026-03-06

5fr SBRT

138 enrolled

Solid Tumors With Oligometastatic Spread

NCT01843374 2026-03-05

Tremelimumab

571 enrolled 19 charts

Diabetes Mellitus, Insulin-Dependent, 12, Mesothelioma, Malignant

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT07246863 2026-03-04

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

131 enrolled

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT07450352 2026-03-04

SEED-CRYO: Sequential 125I Seed Implantation Followed by Cryoablation vs Single-Modality Local Therapy in Unresectable Solid Tumors

150 enrolled

Unresectable Solid Tumors

NCT07028281 2026-03-03

A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors

120 enrolled

Malignant Solid Tumors

NCT04469530 2026-02-27

AflacST1903

55 enrolled

Solid Tumor

NCT06410209 2026-02-27

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

190 enrolled

Hematopoietic and Lymphatic System Neoplasm

NCT07098988 2026-02-27

Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC

107 enrolled

Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT07437625 2026-02-27

Lesion-Allocated Therapy for Multiple Metastases and Tumor-Zoned Treatment for Bulky Tumors: A Phase II Study of Iodine-125 Seed Implantation Combined With Cryoablation in High-Burden Metastatic Disease

90 enrolled

High-Burden Metastatic Solid Tumors

NCT07417501 2026-02-18

Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification

60 enrolled

Solid Tumors

NCT05504291 2026-02-17

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

26 enrolled

Retinoblastoma

NCT06629584 2026-02-17

Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

40 enrolled

Malignant Solid Tumors

NCT05631262 2026-02-13

SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors

321 enrolled